Drug intelligence / Profile preview

Shenzhuo Recipe

Development stage: Preclinical
Lead developer: Guang'anmen Hospital
Modality: Small Molecules
Administration: Oral

Overview

Shenzhuo Recipe is a Traditional Chinese Medicine (TCM) formulation currently under investigation for the treatment of diabetes kidney disease. It is specifically designed to address the 'qi deficiency and blood stasis syndrome' associated with the condition. The recipe is being studied in clinical trials, where it is administered in combination with standard basic treatment.

Other names: 中药肾浊方

Targets

VEGFA (Vascular endothelial growth factor A)HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on Shenzhuo Recipe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhuo Recipe.

Explore the full profile